Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alternate Day Buprenorphine Administration
NCT00000234Phase 2Completed
- Sponsor
- The University of Vermont
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of buprenorphine in opioid use disorder (OUD) (2 arms), sponsored by The University of Vermont. Primary endpoints: Drug use, Opioid withdrawal and 2 more. Status: completed.
02
Drugs
buprenorphine
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT00000234.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000234.